Published in
Sociedade Portuguesa de Pneumologia, Revista Portuguesa de Pneumologia (English Edition), 3(15), p. 555-559
DOI: 10.1016/s2173-5115(09)70132-0
Sociedade Portuguesa de Pneumologia, Revista Portuguesa de Pneumologia (English Edition), 3(15), p. 560-566
DOI: 10.1016/s2173-5115(09)70133-2
Links
Tools
Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Journal article published in 2009 by
António Araújo 
,
Wojciech Bartminski
,
Wojciech Bartminski
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 